Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Based on their tunable physicochemical properties and the possibility of producing cell-specific platforms through surface modification with functional biomolecules, nanoparticles (NPs) represent highly promising tools for biomedical applications. To improve their potential under physiological conditions and to enhance their cellular uptake, combinations with cell-penetrating peptides (CPPs) represent a valuable strategy. CPPs are often cationic peptide sequences that are able to translocate across biological membranes and to carry attached cargos inside cells and have thus been recognized as versatile tools for drug delivery. Nevertheless, the conjugation of CPP to NP surfaces is dependent on many properties from both individual components, and further insight into this complex interplay is needed to allow for the fabrication of highly stable but functional vectors. Since CPPs per se are nonselective and enter nearly all cells likewise, additional decoration of NPs with homing devices, such as tumor-homing peptides, enables the design of multifunctional platforms for the targeted delivery of chemotherapeutic drugs. In this review, we have updated the recent advances in the field of CPP-NPs, focusing on synthesis strategies, elucidating the influence of different physicochemical properties, as well as their application in cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · cited 2×
“In fact, their fate is highly influenced by their physicochemical properties, such as particle size and surface modification, that determine the biodistribution, blood circulation time, protein corona formation, toxicity, and immunological response [52].”
BackgroundDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“The tunable physicochemical properties, which rely mainly on the choice of lipid and the preparation method, along with their high biocompatibility has led to the first FDA approved nano-drug in 1995, Doxil®, doxorubicin-loaded liposome [34].”
BackgroundAtomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
Jin, R., Zeng, C., Zhou, M., & Chen, Y. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00703 · Cited by 3,459 · cited 1×
“The occurrence of size- and shape-dependent surface plasmon resonance (SPR) has led to the fabrication of gold NPs in various sizes and shapes, including rod-shaped, star-shaped, and nanoshells [41].”
BackgroundNear-infrared fluorophores for biomedical imaging
Hong, G., Antaris, A. L., & Dai, H. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0010 · Cited by 2,985 · cited 1×
“Other near infrared-emitting structures, such as carbon nanotubes or lanthanide-doped NPs, are likewise useful for bioimaging and PTT applications; however, their potential toxicity has so far limited their employment in clinical trials [43].”
BackgroundCellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundThe third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791 · cited 1×
“The controlled killing of diseased cells is commonly performed through the application of heat (photothermal therapy, hyperthermia), ultrasound, radiation, activation of reactive oxygen species (photodynamic therapy), gene and immune-modulation, the delivery of high payloads of drug molecules, or combinations thereof…”
BackgroundFutaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundEndosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561 · cited 1×
“Following this mediates endosomal swelling and disruption with the final release of the entrapped cargo [20].”
BackgroundGreen, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
Background
Cited by
Items 201–213 of 213
Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin
Varol, G. D., Karamese, M., Uzum, S., Bayer, K., Kuru, R. S., Bacanli, M. G., Altuntaş, S., Önder, S., & Kaleli‐Can, G. (2026) · Journal of Biomaterials Applications · doi:10.1177/08853282261460756
Advanced therapy medicinal products for local treatment using new delivery methods
Zaradzki, M., Soethoff, J. P., Sauer, S., Remes, A. K., Müller, O. J., Wagner, A. H., & Morath, B. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118268
Salve, C., Bohra, S., More, A., & Singh, B. (2026) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_97_26
Wang, S., Hua, X., Ma, X., Wang, L., Wang, J., Liu, H., Nie, F., Zhao, Y., Zhou, Q., Valdivia, H. H., et al. (2026) · ChemBioChem · doi:10.1002/cbic.70522
Computational Platforms for Membrane-Active Peptide Therapeutic Design
Zan, B., Chen, C. H., Sabha, M., Wu, K., Kadri, M., Nwajiaku, O. L., Hoogland, D., Ulmschneider, J. P., & Ulmschneider, M. B. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.6c00100
Chitosan in Modern Pharmacotherapy: Chitosan Nanoparticles and Delivery Systems
Lažauskas, R., Stanevičienė, I., & Kuršvietienė, L. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091118 · Cited by 1
Shetty, P., Shukla, S., Phatale, V., Devi, A., Chaure, P., Srivastava, A., Khairnar, P., & Srivastava, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127383
Chakrabarty, S., Sarkar, M., Saha, S., Das, S., Howlader, K., Sen, N., Barman, A., & Ghosh, A. (2026) · Nanoscale · doi:10.1039/d6nr02160c
Amphiphilic Peptide Fusion Promotes Endocytic Uptake of Nanodiscs
Carbajal, B. S. P., Reinhardt, T. G., Semenske, J. A., Ji, Z., Jacobs, C. O., & Zeno, W. F. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c01154
Bioinspired and biomimetic nanomaterials for advancing nanomedicine
Vișan, A. I., Anghel, S., Neguț, I., & Hapenciuc, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45321-2.00005-9
Structure-Based Engineering for PTPσ-Targeted Therapeutic Development
Kim, H., & Ryu, S. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198659
“Liposomal, lipid-nanoparticle, polymeric-nanoparticle, or local depot formulations could additionally protect ISP from extracellular degradation and provide controlled CNS or lesion-site exposure [50].”
Peptide-protein interactions in drug discovery
Ying, H., Lei, Y., Luo, Y., Zeng, J., & de la Fuente‐Núñez, C. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100598
Firjatullah, R. I., Prabowo, M. H., & Kesuma, A. P. (2026) · EKSAKTA Journal of Sciences and Data Analysis · doi:10.20885/eksakta.vol7.iss2.art4
Metadata
- Authors
- Gessner, I., & Neundorf, I.
- Affiliations
- University of Cologne (DE)
- Corresponding author
- Neundorf, Ines
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-06
- Volume
- 21
- Issue
- 7
- Pages
- 2536
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7177461
- OpenAlex
- W3014732989
- Cited by
- 212
- References
- 115
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 37 · 2023: 40 · 2022: 35 · 2021: 35 · 2020: 9
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (NE 1419/10-1)
- European Commission (MSCA-ITN-ETN MAGICBULLET RELOADED 861316)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- cell-penetrating peptides, nanoparticles, surface modification, tumor-homing peptides, targeted drug delivery, cancer diagnosis, cancer therapy, cellular uptake, physicochemical properties, cationic peptides
- MeSH terms
- Theranostic Nanomedicine, Animals, Antineoplastic Agents, Drug Carriers, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles, Chemical Phenomena, Cell-Penetrating Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.